Respiratory syncytial virus (RSV): What to know, including symptoms, how to know when it’s serious, who has a high risk, treatment, prevention, and more.

The respiratory syncytial virus (RSV) ... Newer RSV mAbs incorporate mutations that prolong their half-life, thereby conferring LRTI protection for a full RSV season.

Each year, RSV results in millions of outpatient visits for young children, tens of thousands of hospitalizations among children and adults aged 65 and older, and thousands of deaths. This winter ...

Respiratory syncytial virus (RSV) is a common germ that can infect the nose, throat, lungs, and breathing passages. For most healthy children and adults, RSV can result in mild, cold-like symptoms.

Chicago, June 09, 2025 (GLOBE NEWSWIRE) -- The global respiratory syncytial virus treatment market valued at USD 2,387.2 million in 2024 and is projected to reach USD 8,332.5 million by 2033 ...

This year, emergency departments nationwide are seeing an unusually early surge in very young and elderly patients with respiratory distress, often caused by respiratory syncytial virus or RSV. We ...

Respiratory syncytial virus is a seasonal respiratory virus that usually causes mild, cold-like symptoms. Most people recover in a week or two, but RSV can be serious, especially for infants and older ...

Respiratory Syncytial Virus or RSV is one of the most common respiratory viruses circulating today. Often thought of as only being dangerous to babies and toddlers due to how often child-related ...

Respiratory syncytial virus (RSV) is a common viral infection that may lead to serious complications in certain groups. Since 2023, vaccines are now available and are highly recommended ...

Respiratory syncytial virus (RSV) is a common germ that can settle into your lungs and airways. It's the top cause of upper respiratory infection in babies and toddlers, but anyone can get it.

Respiratory Syncytial Virus Is the Flu-Like Illness You Haven’t Heard About. Here’s what to look out for. By Korin Miller and Ashley Abramson. October 23, 2024. sestovic/Getty Images ...

A single dose of respiratory syncytial virus vaccine was effective against infections and associated hospitalizations in veterans aged at least 60 years during the 2023-24 season.